Conference Reports for NATAP

62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back

In Vitro Selection of Resistance to GS-9451, a Novel and Potent Inhibitor of HCV NS3 Protease       Reported by Jules Levin AASLD Nov 5-8 2011 SF   H. Yang, T. Appleby, X. Chen, and W. Delaney IV Gilead Sciences, Foster City, CA United States